RNXT financials
RenovoRx (RNXT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- RNXT revenue was $1.12M in fiscal 2025, net income -$11.17M.
RNXT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.12M | $796.00K | -$12.51M | -$11.17M | -0.32 |
| 2024 | $43.00K | $43.00K | -$10.97M | -$8.81M | -0.40 |
| 2023 | – | – | -$11.40M | -$10.23M | -0.99 |
| 2022 | – | – | -$9.95M | -$9.89M | -1.09 |
| 2021 | – | – | -$5.67M | -$6.32M | -1.21 |
| 2020 | – | – | -$3.20M | -$3.80M | -1.72 |